Compare Ralph Lauren Corp (RL) vs Royalty Pharma plc Class A Ordinary Shares (RPRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ralph Lauren Corp vs Royalty Pharma plc Class A Ordinary Shares — how do they compare? Ralph Lauren Corp trades at $371.24 (market cap $21.89B), while Royalty Pharma plc Class A Ordinary Shares trades at $56.96 (market cap $25.27B). The key difference: Royalty Pharma plc Class A Ordinary Shares is the larger of the two by market cap, and Royalty Pharma plc Class A Ordinary Shares pays the higher dividend (1.66%). Which is the better fit depends on your goals — on Pluang, investors hold Ralph Lauren Corp for 84 Days and Royalty Pharma plc Class A Ordinary Shares for 1 Days on average.
| RL | RPRX | |
|---|---|---|
Market Cap | $21.89B | $25.27B |
Volume | 481,617 | 3,671,183 |
Sector | Consumer Cyclical | Health |
52-Week High | $414.25 | $63.96 |
52-Week Low | $309.29 | $35.44 |
Typical Hold Time | 84 Days | 1 Days |
Enterprise Value | $22.95B | $32.50B |
Dividend Yield | 1.09% | 1.66% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Ralph Lauren (RL) trades at $370.82, up 2.68% on the day, with a bullish technical signal from moving averages but overbought RSI readings. The company shows strong fundamentals with revenue growth to $7.08B in 2025, net income margin of 11.76%, and consistent earnings beats. Recent news highlights dividend declarations, global expansion, and sustainability progress, supporting positive sentiment.
Outlook remains favorable with analyst consensus price target of $456.67 implying 23% upside, though risks include competitive pressures and potential economic slowdown. Earnings momentum and brand strength provide tailwinds, but investors should monitor execution on growth initiatives amid market volatility.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ralph Lauren Corp
Founded by designer Ralph Lauren in 1967, Ralph Lauren Corp. designs, markets, and distributes lifestyle products in North America, Europe, and Asia. Its products include apparel, footwear, eyewear, jewelry, leather goods, home products, and fragrances. The company's brands include Ralph Lauren Collection, Polo Ralph Lauren, Lauren Ralph Lauren, and Double RL. Distribution channels for Ralph Lauren include wholesale (including department stores and specialty stores), retail (including company-owned retail stores and e-commerce), and licensing.
Read more on RL →About Royalty Pharma plc Class A Ordinary Shares
Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →
